
Curve Biosciences is the Whole-Body Intelligence company. Curve has created the first molecular blueprint of the human body by manually curating the world's largest collection of comprehensively-characterized tissue samples into its Whole-Body Atlas. Trained on the clarity of this atlas, the company's Whole-Body Intelligence models identify chronic disease states through its Whole-Body Blood Tests earlier and more accurately than other methods. Curve's mission is to provide doctors the best intelligence for their patients and to alleviate the pain of chronic diseases by anchoring medicine in biological truth. The company is based in San Mateo, CA.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/29/25 | $40,000,000 |
Civilization Ventures First Spark Ventures Incite Ventures LifeX Ventures Luma Group ![]() Micah Spear Mintaka VC NZVC Techas Capital | undisclosed |